Dopamine-β-hydroxylase activity and levels of its cofactors and other biochemical parameters in the serum of arsenicosis patients of Bangladesh

International Journal of Biomedical Science

Volumn 10, Issue 1, 2014, Pages 52-60

  Khalilur Rahman, M ^a   Iqbal Choudhary, M ^b   Arif, M ^a   Monzur Morshed, M ^a  

^a UNIVERSITY OF DHAKA   (Bangladesh)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Arsenicosis; Dopamine hydroxylase; Drinking water; Norepinephrine; Serum

Indexed keywords

ADRENALIN; ARSENIC; ASCORBIC ACID; COPPER; DOPAMINE BETA MONOOXYGENASE; GLUCOSE; NORADRENALIN; RETINOL; ZINC;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARSENIC POISONING; ARTICLE; BANGLADESH; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; MALE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SCHOOL CHILD; VERY ELDERLY; VITAMIN BLOOD LEVEL; WATER CONTAMINATION; WATER SAMPLING; ZINC BLOOD LEVEL;

EID: 84897824715     PISSN: 15509702     EISSN: 15552810     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bangladesh Arsenic News News Letter: Arsenic Toxicity in Bangladesh. 1997; 1 (1): 1-10. (A publication of Bangladesh Center for Advanced Studies).
2. Chakrabarty D. Arsenic in ground water: cause, effect and remedy. SOES Intl. Conference, School of Envirnmental Studies (SOES), Jadavpur, Calcutta, February, 1995.
3. Khan AW, Ahmad SA, Sayed MH, Hadi SA. Arsenic contamination in ground water and its effect on health with particular reference to Bangladesh. J. Prev. Soc. Med. 1997; 16 (1): 65-73.
4. Arsenic: Environmental Health Criteria. Geneva: WHO. 1981; p174.
5. st Ed. 1997. Dhaka Community Hospital, 1089, Malibagh, Dhaka. 1997; p7-36.
6. Hotta N. Clinical aspects of chronic arsenic poisoning due to environmental and occupational pollution in and around a small refinining spot. Jap. J. Cons. Med. 1998; 53 (1, 2): 49-70.
7. Astolfi E, Maccagno A, Fernandez JCG, Vaccara R, et al. Relation between arsenic and skin cancer. Biological Trace Element Research. 1981; 3: 133-143.
8. Weishilboum R, Axelrod J. Serum dopamine-β-hydroxylase activity. Circ. Res. 1971; 28: 307-315.
9. Reid H, Kopin IJ. Significance of plasma dopamine-β-hydroxylase activity as an index of sympathetic neuronal function. Proc. Natl. Acad. Sci. USA. 1974; 71: 4392-4394.
10. Creveline CR, Daly J, Witkop B, Udenfriend S. Substrate and Inhibitors of dopamine-β-hydroxylase. Biochem. Biophy. Acta. 1962; 64: 125-134.
11. Levine EY, Lovenberg W, Kaufman S. The enzymatic conversion of 3,4-dihydroxy phe-Nylethylamine to norepinephrine. J. Biol. Chem. 1960; 235: 2080-2086.
12. Udenfriend S, Creveline CR. Localization of dopamine-β-hydroxylase in brain. J. Neurochem. 1959: 4: 350-352.
13. Potter IT, Axelrod J. Subcellular localization of catecholamines in tissues of the macol. Exp. Therap. 1963; 142: 291-298.
14. Nagatsu T, Schoot LBV, Levitt M, Udenfriend S. Factors influencing dopamine-β-hydroxylase activity and epinephrine levels in guineapig adrenal gland. J. Biochem. 1968; 64: 19-43.
15. Lovenberg W, Bruckwick EA, Alexander RW, Horwitz, et al. Evaluation of serum dopamine-β-hydroxylase activity as an index of sympathetic nervous activity in man. Adv. Biochem. Psychopharmacol. 1974; 12: 121-128.
16. Rahman MK, Choudhary MI, Islam MR, Rahman MH. Developmental changes of catecholamine-mediating enzyme-dopamine-β-hydroxylase and its cofactors in central and peripheral tissues and serum of Long-Evans rats. Int. J. Biomed. Sci. 2012; 8 (3):194-203.
17. Okada T, Ohta T, Kato T, Ikuta K, et al. Dopamine-β-hydroxylase activity in serum and cerebrospinal fluid in neuropshychiatric didease. Neuropsychobiol. 1976; 2: 139-144.
18. Nagatsu T, Yamaguchi T, Rahman MK, Trocewicz J, et al. Catecholamine related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases. Adv. Neurol. 1984; 40: 467-473.
19. Kato T, Kuzuya H, Nagatsu T. A simple and sensitive assay for dopamine-β-hydroxylase activity by dual-wavelength spectrophotometry. Biochem. Med. 1974; 10: 320-328.
20. Rahman Mk, Rahman F, Rahman T, Kato T. Dopamine-β-hydroxylase (DBH), its cofactors and other biochemical parameters in the serum of neurological patients in Bangladesh. Int. J. Biomed. Sci. 2009; 5 (4): 395-401.
21. Robertson D, Hollister AS, Biaggioni I. Dopamine-β-hydroxylase deficiency and cardiovascular control. Hypertension. 1991; 18: 1-8.
22. Robertson D, Haile V, Robertson RM. Phillips JA, et al. Dopamine-β-hydroxylase deficiency: A genetic disorder of cardiovascular regulation. Hypertension: American Heart Assoc. 1991; 18 (1): 1-8.
23. First sysmptom of DBH deficiency often starts during complicated perinatal period with hypotension, muscle hypotonia, hypothermia and hypoglycemia. Google Search.
24. Kim YK, Quadro L, Reverse-phase HPLC analysis of retinol and retinyl esters in mouse serum and tissues. Methods Mol. Biol. 2010; 652: 263-275.
25. Hesse GW, Hesse KA, Cataianatto F. Behavioral characteristics of rats experiencing chronic Zinc deficiency. Physiol. Behav. 1979; 22: 211-215.
26. Rahman M, Tandel M, Ahmed SA, Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am. J. Epidemiol. 1998; 148 (2): 198-203.
27. Rammelt C, Masud ZA, Boes J Masud F. Beyond medical treatment, arsenic poisoning in rural Bangladesh. Soc. Med. 2011; 6 (1): 22-30.